Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Novel Pyrimidine-5-carboxamide Compounds as NNMT Inhibitors for Treating Diabetes.

Literature DB >> 33859793

Novel Pyrimidine-5-carboxamide Compounds as NNMT Inhibitors for Treating Diabetes.

Ram W Sabnis¹.

Abstract

Entities: Chemical

Year: 2021 PMID： 33859793 PMCID： PMC8040032 DOI： 10.1021/acsmedchemlett.1c00150

Source DB: PubMed Journal: ACS Med Chem Lett ISSN： 1948-5875 Impact factor: 4.345

× No keyword cloud information.

5 in total

Review 1. Impaired nicotinamide adenine dinucleotide (NAD⁺ ) metabolism in diabetes and diabetic tissues: Implications for nicotinamide-related compound treatment.

Authors: Lan Fan; Jose M Cacicedo; Yasuo Ido
Journal: J Diabetes Investig Date: 2020-05-19 Impact factor: 4.232

Review 2. Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation.

Authors: Annalisa Roberti; Agustín F Fernández; Mario F Fraga
Journal: Mol Metab Date: 2021-01-14 Impact factor: 7.422

Review 3. Hepatocyte nuclear factor 1 beta: A perspective in cancer.

Authors: Shubhra Chandra; Srilakshmi Srinivasan; Jyotsna Batra
Journal: Cancer Med Date: 2021-02-13 Impact factor: 4.452

Review 4. Role of NAD⁺ in regulating cellular and metabolic signaling pathways.

Authors: Sara Amjad; Sabah Nisar; Ajaz A Bhat; Ab Rauf Shah; Michael P Frenneaux; Khalid Fakhro; Mohammad Haris; Ravinder Reddy; Zoltan Patay; Joseph Baur; Puneet Bagga
Journal: Mol Metab Date: 2021-02-17 Impact factor: 7.422

Review 5. New insights into molecules and pathways of cancer metabolism and therapeutic implications.

Authors: Zhenye Tang; Zhenhua Xu; Xiao Zhu; Jinfang Zhang
Journal: Cancer Commun (Lond) Date: 2020-11-10

5 in total

3 in total

Novel Pyrimidine-5-carboxamide Compounds as NNMT Inhibitors for Treating Diabetes.

Review 1. Impaired nicotinamide adenine dinucleotide (NAD⁺ ) metabolism in diabetes and diabetic tissues: Implications for nicotinamide-related compound treatment.

Review 2. Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation.

Review 3. Hepatocyte nuclear factor 1 beta: A perspective in cancer.

Review 4. Role of NAD⁺ in regulating cellular and metabolic signaling pathways.

Review 5. New insights into molecules and pathways of cancer metabolism and therapeutic implications.

Review 1. Nicotinamide N-Methyltransferase: An Emerging Protagonist in Cancer Macro(r)evolution.

Review 2. Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms.

Review 3. Complex roles of nicotinamide N-methyltransferase in cancer progression.

Novel Pyrimidine-5-carboxamide Compounds as NNMT Inhibitors for Treating Diabetes.

Review 1. Impaired nicotinamide adenine dinucleotide (NAD+ ) metabolism in diabetes and diabetic tissues: Implications for nicotinamide-related compound treatment.

Review 2. Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation.

Review 3. Hepatocyte nuclear factor 1 beta: A perspective in cancer.

Review 4. Role of NAD+ in regulating cellular and metabolic signaling pathways.

Review 5. New insights into molecules and pathways of cancer metabolism and therapeutic implications.

Review 1. Nicotinamide N-Methyltransferase: An Emerging Protagonist in Cancer Macro(r)evolution.

Review 2. Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms.

Review 3. Complex roles of nicotinamide N-methyltransferase in cancer progression.

Review 1. Impaired nicotinamide adenine dinucleotide (NAD⁺ ) metabolism in diabetes and diabetic tissues: Implications for nicotinamide-related compound treatment.

Review 4. Role of NAD⁺ in regulating cellular and metabolic signaling pathways.